Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) hit a new 52-week low during mid-day trading on Friday following a weaker than expected earnings announcement. The company traded as low as $25.59 and last traded at $25.73, with a volume of 62907 shares trading hands. The stock had previously closed at $34.68.
The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $665.21 million for the quarter, compared to analyst estimates of $617.24 million.
Analyst Ratings Changes
A number of research analysts have recently weighed in on the company. Truist Financial lowered their price target on Astrana Health from $59.00 to $50.00 and set a "buy" rating on the stock in a report on Monday, January 13th. Robert W. Baird lowered their target price on Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a research note on Monday. Stifel Nicolaus reduced their price target on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research report on Thursday, February 20th. Bank of America lowered their price objective on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a research report on Tuesday. Finally, Macquarie upgraded shares of Astrana Health to a "hold" rating in a research note on Monday, December 16th. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $56.83.
Check Out Our Latest Research Report on Astrana Health
Hedge Funds Weigh In On Astrana Health
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Janus Henderson Group PLC acquired a new position in shares of Astrana Health during the 3rd quarter worth $1,164,000. Royce & Associates LP bought a new stake in Astrana Health in the third quarter worth $6,661,000. Amalgamated Bank acquired a new position in Astrana Health during the third quarter worth $713,000. Principal Financial Group Inc. bought a new position in Astrana Health during the third quarter valued at about $13,383,000. Finally, Loomis Sayles & Co. L P bought a new position in Astrana Health during the third quarter valued at about $30,251,000. Institutional investors own 52.77% of the company's stock.
Astrana Health Stock Up 1.1 %
The company has a market cap of $1.51 billion, a price-to-earnings ratio of 20.60, a PEG ratio of 1.37 and a beta of 1.20. The business has a 50-day simple moving average of $34.70 and a two-hundred day simple moving average of $44.31. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60.
Astrana Health Company Profile
(
Get Free Report)
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Articles
Before you consider Astrana Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.
While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
